Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma

por Reznik, Robert, Hendifar, Andrew E., Tuli, Richard
Publicado 2014

A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed

por Gong, Jun, Delioukina, Maria L., Hendifar, Andrew E.
Publicado 2013

Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma

por Ebia, Matthew I., Hitchins, Megan P., Hendifar, Andrew E.
Publicado 2023

Meta-analyses of treatment standards for pancreatic cancer

por GONG, JUN, TULI, RICHARD, SHINDE, ARVIND, HENDIFAR, ANDREW E.
Publicado 2016

Best Practices for the Coordinated Care of Patients With Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy

por Hendifar, Andrew E., Mehr, Samuel H., McHaffie, Derek R.
Publicado 2022

Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary

por Hendifar, Andrew E., Ramirez, Robert A., Anthony, Lowell B., Liu, Eric
Publicado 2019

Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination

por Gong, Jun, Le, Thang Q., Massarelli, Erminia, Hendifar, Andrew E., Tuli, Richard
Publicado 2018

Remote Oncology Care: Review of Current Technology and Future Directions

por McGregor, Bradley A, Vidal, Gregory A, Shah, Sumit A, Mitchell, James D, Hendifar, Andrew E
Publicado 2020

Pancreatic cancer ‘mismatch’ in Lynch syndrome

por Hendifar, Andrew E, Larson, Brent K, Rojansky, Rebecca, Guan, Michelle, Gong, Jun, Placencio, Veronica, Tuli, Richard, Hitchins, Megan
Publicado 2019

Pancreas Cancer‐Associated Weight Loss

por Hendifar, Andrew E., Petzel, Maria Q.B., Zimmers, Teresa A., Denlinger, Crystal S., Matrisian, Lynn M., Picozzi, Vincent J., Rahib, Lola
Publicado 2018

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms

por Guan, Michelle, He, Ingrid, Luu, Michael, David, John, Gong, Jun, Placencio-Hickok, Veronica R., Reznik, Robert S., Tuli, Richard, Hendifar, Andrew E.
Publicado 2019

Pancreatic cancer cachexia: a review of mechanisms and therapeutics

por Tan, Carlyn R., Yaffee, Patrick M., Jamil, Laith H., Lo, Simon K., Nissen, Nicholas, Pandol, Stephen J., Tuli, Richard, Hendifar, Andrew E.
Publicado 2014

Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients

por Gresham, Gillian, Hendifar, Andrew E., Spiegel, Brennan, Neeman, Elad, Tuli, Richard, Rimel, B. J., Figlin, Robert A., Meinert, Curtis L., Piantadosi, Steven, Shinde, Arvind M.
Publicado 2018

Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data

por Baecker, Aileen, Kim, Sungjin, Risch, Harvey A., Nuckols, Teryl K., Wu, Bechien U., Hendifar, Andrew E., Pandol, Stephen J., Pisegna, Joseph R., Jeon, Christie Y.
Publicado 2019

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations

por Gong, Jun, Blais, Edik M., Bender, Joseph R., Guan, Michelle, Placencio-Hickok, Veronica, Petricoin, Emanuel F., Pishvaian, Michael J., Gregory, Gary, Tuli, Richard, Hendifar, Andrew E.
Publicado 2019

Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma

por Wang, Nan, Gaddam, Srinivas, Xie, Yibin, Christodoulou, Anthony G., Wu, Chaowei, Ma, Sen, Fan, Zhaoyang, Wang, Lixia, Lo, Simon, Hendifar, Andrew E., Pandol, Stephen J., Li, Debiao
Publicado 2023

Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol

por Gong, Jun, Osipov, Arsen, Lorber, Jeremy, Tighiouart, Mourad, Kwan, Albert K., Muranaka, Hayato, Akinsola, Rasaq, Billet, Sandrine, Levi, Abrahm, Abbas, Anser, Davelaar, John, Bhowmick, Neil, Hendifar, Andrew E.
Publicado 2023

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review

por Macarulla, Teresa, Hendifar, Andrew E., Li, Chung-Pin, Reni, Michele, Riess, Hanno, Tempero, Margaret A., Dueck, Amylou C., Botteman, Marc F., Deshpande, Chinmay G., Lucas, Eleanor J., Oh, Do-Youn
Publicado 2020

Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

por Gupta, Arjun, Khalid, Omar, Moravek, Cassadie, Lamkin, Anica, Matrisian, Lynn M., Doss, Sudheer, Denlinger, Crystal S., Coveler, Andrew L., Weekes, Colin D., Roeland, Eric J., Hendifar, Andrew E., Nipp, Ryan D.
Publicado 2021

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan

por Yu, Kenneth H., Hendifar, Andrew E., Alese, Olatunji B., Draper, Amber, Abdelrahim, Maen, Burns, Ethan, Khan, Gazala, Cockrum, Paul, Bhak, Rachel H., Nguyen, Catherine, DerSarkissian, Maral, Duh, Mei Sheng, Bahary, Nathan
Publicado 2021